StockData
Gelteq Ltd logo

Gelteq Ltd (GELS) stock

GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 16, 2026Score 0/30
$0.27−0.09 (-25.05%)

Close on Nov 17, 2026Market cap $2.88MP/E –Yield –

Gelteq price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Gelteq's price to sales ratio was 34.3× on Nov 11, 2026, against 92.3× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202634.3×−32.9
2025Dec 31, 202567.1×–

More Gelteq figures

See a number that looks wrong?